In our study, RBCK1 was highly associated with infiltration of many immune cells.The effect of RBCK1 on immune function may be responsible for the differences in sensitivity to immunotherapy and drug treatment in CM patients with different risks. This evidence concerns the gene RBCK1 and cutaneous mastocytosis.